US Stock Market Closed

Dashboard

Novocure Ltd. (NVCR)

Current

- (-)

After Hours

Rating & Fair Value

Fair Value Premium lock
Institutional Holdings

H

Financial Strength

H

Sustainable Growth

B

Industry Comparison

B

Management & Equity

B

Analyst Opinion

B

Leverage & Liquidity

B

Fundamental Variables

H

Rating Performance

FV Performance

*There is a current rating on the stock that is included in these numbers based on its performance so far

About

NovoCure Ltd. develops treatment for tumors. Its platform is called the Tumor Treating Field which used electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.

CEO

Asaf Danziger

Employees

782

Industry

Specialized Medical Devices

Sector

Healthcare

Headquarters

St. Helier

Exchange

NASDAQ

Summary Stats

Market Cap

7.67B

Revenue

545M

Net Income

-68.2M

EPS

-$0.66

Price-to-Earnings

-111.72

Price-to-Book

17.36

Debt-to-Equity

1.63

News

Analyst Ratings

Price targets projected by 8 analysts

High

$200.00

Average

$126.00

Low

$86.00

Ratings calculated by 9 analysts

Buy

3

Hold

5

Sell

1

Last Dividend

Amount

-

Dividend Date

-

Frequency

-

Dividend Yield

Earnings

Most Recent Earnings

Last Earnings for Q2 2022

Last Earnings

Missed by -$0.08

Actual

-$0.23 -53.3%

Consensus

-0.15

Report Date

Year Ago

-0.14

Year Ago Change %

Down 64%

Actual vs Estimates

XX

xxx

Upcoming Estimates Unavailable

Expected EPS
-

-

Actual EPS
-

--

Competitors

star Favorites